Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 2 Distribution of founder mutations of the BRCA1 gene in ovarian cancer patient

From: Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients

Germline mutation All ovarian cancer (n = 125)
5382insC [exon 20] 12/125 (9.6 %)
300 T > G [exon 5] 3/125 (2.4 %)
4153delA [exon 11.17] 2/125 (1.6 %)
All mutations 17/125 (13.6 %)